PATENT CLAIM ANALYSIS

Application Number: 15860741
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["435", "072000"]

Abstract:
This invention relates to generally inhibiting histone deacetylase (“HDAC”) enzymes (e.g., HDAC1, HDAC2, and HDAC3).

Claim (Index 101):
The method of  claim 90 , wherein each of R 2  and R 3  is hydrogen.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.19048
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13843261', '15346877', '13823708', '14598583', '14773472']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6630452130337398
- 35 USC 102 Novelty (BERT): 0.5903752598794741
- Combined Prediction Score: 0.6557782177183132
- Mean Citation Score: 459.948696
- Max Citation Score: 513.3397
- Similarity Product: 432.188644160068

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test